Robert Charles Hider
Robert Charles Hider is a renowned pharmacologist and biochemist known for his significant contributions to the field of drug discovery and medicinal chemistry. His research has led to the development of several novel therapeutic agents, particularly in the area of cancer treatment.
Early Life and Education[edit | edit source]
Robert Charles Hider was born in London, England. He developed an interest in science at a young age, which led him to pursue a degree in chemistry at the University of London. After completing his undergraduate studies, Hider continued his education at the same university, earning a PhD in biochemistry.
Career[edit | edit source]
Following his graduation, Hider began his career as a research scientist at the University of London. His research focused on the development of new drugs for the treatment of various diseases, particularly cancer. Hider's work in this area has been instrumental in the discovery of several novel chemotherapeutic agents.
In addition to his research, Hider has also made significant contributions to the field of education. He has held several teaching positions at the University of London, where he has mentored numerous students and young scientists. Hider's dedication to teaching has earned him several awards and recognitions.
Contributions to Pharmacology[edit | edit source]
Hider's most notable contributions to pharmacology are in the area of iron chelation therapy. His research in this field has led to the development of several new drugs that are currently used in the treatment of iron overload conditions. Hider's work in this area has not only improved the lives of patients suffering from these conditions, but has also significantly advanced our understanding of iron metabolism and its role in disease.
Awards and Recognitions[edit | edit source]
Over the course of his career, Hider has received numerous awards and recognitions for his contributions to pharmacology and biochemistry. These include the Royal Society of Chemistry's Award for Medicinal Chemistry and the British Pharmacological Society's Award for Outstanding Contributions to Pharmacology.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
